SG11202001941SA - Non-integrating dna vectors for the genetic modification of cells - Google Patents
Non-integrating dna vectors for the genetic modification of cellsInfo
- Publication number
- SG11202001941SA SG11202001941SA SG11202001941SA SG11202001941SA SG11202001941SA SG 11202001941S A SG11202001941S A SG 11202001941SA SG 11202001941S A SG11202001941S A SG 11202001941SA SG 11202001941S A SG11202001941S A SG 11202001941SA SG 11202001941S A SG11202001941S A SG 11202001941SA
- Authority
- SG
- Singapore
- Prior art keywords
- cells
- genetic modification
- dna vectors
- integrating dna
- integrating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/55—Vectors comprising a special origin of replication system from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17191829.5A EP3456821B2 (en) | 2017-09-19 | 2017-09-19 | Non-integrating dna vectors for the genetic modification of cells |
| PCT/EP2018/075353 WO2019057773A1 (en) | 2017-09-19 | 2018-09-19 | Non-integrating dna vectors for the genetic modification of cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202001941SA true SG11202001941SA (en) | 2020-04-29 |
Family
ID=60037350
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202001941SA SG11202001941SA (en) | 2017-09-19 | 2018-09-19 | Non-integrating dna vectors for the genetic modification of cells |
| SG11202002367WA SG11202002367WA (en) | 2017-09-19 | 2018-09-19 | Non-integrating dna vectors for the genetic modification of cells |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202002367WA SG11202002367WA (en) | 2017-09-19 | 2018-09-19 | Non-integrating dna vectors for the genetic modification of cells |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20200277624A1 (en) |
| EP (4) | EP3456821B2 (en) |
| JP (3) | JP7263327B2 (en) |
| KR (2) | KR20200079244A (en) |
| CN (1) | CN111278972B (en) |
| AU (2) | AU2018337672A1 (en) |
| CA (2) | CA3017658A1 (en) |
| DK (3) | DK3456821T4 (en) |
| ES (3) | ES2821655T3 (en) |
| FI (2) | FI3456821T4 (en) |
| HU (1) | HUE060893T2 (en) |
| IL (2) | IL273267A (en) |
| LT (1) | LT3684924T (en) |
| MX (1) | MX2020003092A (en) |
| PL (1) | PL3684924T3 (en) |
| PT (1) | PT3684924T (en) |
| SG (2) | SG11202001941SA (en) |
| WO (2) | WO2019060253A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| EP3092049A1 (en) | 2014-01-08 | 2016-11-16 | Flodesign Sonics Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| KR20220066413A (en) | 2017-12-14 | 2022-05-24 | 프로디자인 소닉스, 인크. | Acoustic transducer drive and controller |
| WO2020187889A1 (en) * | 2019-03-18 | 2020-09-24 | Deutsches Krebsforschungszentrum | Expression constructs for the genetic modification of cells |
| CA3151464A1 (en) | 2019-09-18 | 2021-03-25 | Bruce C. SCHNEPP | Synthetic dna vectors and methods of use |
| JP2023537858A (en) | 2020-07-22 | 2023-09-06 | ドイチェス クレブスフォルシュンクスツェントルム | Application of 5'S/MAR |
| CN113025651B (en) * | 2021-03-31 | 2023-03-24 | 重庆医科大学 | Novel application of drug screening cell model, triciribine and structural analogue of targeted HBV core promoter |
| WO2022272297A1 (en) | 2021-06-25 | 2022-12-29 | Oxford Biomedica Solutions Llc | Adeno-associated virus packaging systems |
| CN118055951A (en) | 2021-11-11 | 2024-05-17 | 海德堡大学 | Immunoreactive molecules and uses thereof |
| WO2023083985A1 (en) | 2021-11-11 | 2023-05-19 | Patrick Schmidt | Immunoreactive molecules and uses thereof |
| US20230323395A1 (en) | 2021-12-15 | 2023-10-12 | Homology Medicines, Inc. | Methods and compositions for the production of adeno-associated virus |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888774A (en) | 1994-12-19 | 1999-03-30 | Cangene Corporation | Recombinant DNA molecules and expression vectors for erythropoietin |
| FR2738842B1 (en) | 1995-09-15 | 1997-10-31 | Rhone Poulenc Rorer Sa | CIRCULAR DNA MOLECULE WITH ORIGIN OF CONDITIONAL REPLICATION, THEIR PREPARATION METHOD AND THEIR USE IN GENE THERAPY |
| US5922583A (en) | 1995-10-17 | 1999-07-13 | Biostar Inc. | Methods for production of recombinant plasmids |
| DE19848017A1 (en) | 1998-10-17 | 2000-04-20 | Multigene Biotech Gmbh | Episomally replicating vectors, useful in gene therapy, contain origins of replication and scaffold-matrix attached region sequences but no viral coding sequences |
| FR2821855B1 (en) | 2001-03-09 | 2004-04-02 | Cayla | SYNTHETIC GENES AND BACTERIAL PLASMIDS WITHOUT GIC |
| GB0327056D0 (en) | 2003-11-20 | 2003-12-24 | Cobra Biolog Ltd | Plasmid maintenance |
| TWI311152B (en) | 2004-09-17 | 2009-06-21 | Boehringer Ingelheim Rcv Gmbh & Co K | Host-vector system for antibiotic-free cole1 plasmid propagation |
| NZ554895A (en) * | 2004-11-03 | 2009-06-26 | Almac Diagnostics Ltd | Transcriptome microarray technology and methods of using the same |
| US9068200B2 (en) * | 2005-10-05 | 2015-06-30 | Universita' Degli Studi Milano-Bicocca | Method for the transfer of episomal vectors into animal cells |
| WO2008153733A2 (en) | 2007-05-29 | 2008-12-18 | Nature Technology Corporation | Vectors and methods for genetic immunization |
| CA2726862A1 (en) | 2008-06-30 | 2010-01-21 | Atgcell Inc. | Mammalian cell expression vectors and utilization |
| EP3093351B1 (en) * | 2008-07-09 | 2018-04-18 | Celera Corporation | Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof |
| AU2009280913A1 (en) * | 2008-08-12 | 2010-02-18 | Avesthagen Limited | An expression vector and a method thereof |
| US9045759B2 (en) | 2009-01-21 | 2015-06-02 | James Arthur Williams | DNA plasmids with improved copy number |
| EP2476755A1 (en) | 2011-01-17 | 2012-07-18 | Helmholtz-Zentrum für Infektionsforschung GmbH | S/MAR containing expression vectors, cell and cell lines as well as methods using the same |
| GB201213117D0 (en) | 2012-07-24 | 2012-09-05 | Ucl Business Plc | Transgene expression |
| US9550998B2 (en) * | 2012-08-29 | 2017-01-24 | Nature Technology Corporation | DNA plasmids with improved expression |
| US20150322439A1 (en) * | 2012-11-19 | 2015-11-12 | Nature Technology Corporation | Replicative minicircle vectors with improved expression |
| EP2878674A1 (en) | 2013-11-28 | 2015-06-03 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) | Stable episomes based on non-integrative lentiviral vectors |
| JP6544565B2 (en) | 2015-04-28 | 2019-07-17 | 国立大学法人広島大学 | Method and kit for enhancing expression of target gene in mammalian cells and use thereof |
| WO2020187889A1 (en) * | 2019-03-18 | 2020-09-24 | Deutsches Krebsforschungszentrum | Expression constructs for the genetic modification of cells |
-
2017
- 2017-09-19 EP EP17191829.5A patent/EP3456821B2/en active Active
- 2017-09-19 FI FIEP17191829.5T patent/FI3456821T4/en active
- 2017-09-19 DK DK17191829.5T patent/DK3456821T4/en active
- 2017-09-19 ES ES17191829T patent/ES2821655T3/en active Active
-
2018
- 2018-09-17 WO PCT/US2018/051381 patent/WO2019060253A1/en active Application Filing
- 2018-09-17 US US16/648,885 patent/US20200277624A1/en active Pending
- 2018-09-18 CA CA3017658A patent/CA3017658A1/en active Pending
- 2018-09-19 AU AU2018337672A patent/AU2018337672A1/en active Pending
- 2018-09-19 WO PCT/EP2018/075353 patent/WO2019057773A1/en unknown
- 2018-09-19 ES ES18769377T patent/ES2942210T3/en active Active
- 2018-09-19 JP JP2020516608A patent/JP7263327B2/en active Active
- 2018-09-19 KR KR1020207010722A patent/KR20200079244A/en not_active Application Discontinuation
- 2018-09-19 PL PL18769377.5T patent/PL3684924T3/en unknown
- 2018-09-19 ES ES18769378T patent/ES2887776T3/en active Active
- 2018-09-19 LT LTEPPCT/EP2018/075353T patent/LT3684924T/en unknown
- 2018-09-19 HU HUE18769377A patent/HUE060893T2/en unknown
- 2018-09-19 SG SG11202001941SA patent/SG11202001941SA/en unknown
- 2018-09-19 US US16/649,064 patent/US20200263195A1/en not_active Abandoned
- 2018-09-19 EP EP18769378.3A patent/EP3684925B1/en active Active
- 2018-09-19 US US16/648,768 patent/US20210403941A1/en active Pending
- 2018-09-19 EP EP22201555.4A patent/EP4186975A1/en active Pending
- 2018-09-19 CA CA3076285A patent/CA3076285A1/en active Pending
- 2018-09-19 FI FIEP18769377.5T patent/FI3684924T3/en active
- 2018-09-19 DK DK18769377.5T patent/DK3684924T3/en active
- 2018-09-19 EP EP18769377.5A patent/EP3684924B1/en active Active
- 2018-09-19 JP JP2020516915A patent/JP7189943B2/en active Active
- 2018-09-19 MX MX2020003092A patent/MX2020003092A/en unknown
- 2018-09-19 PT PT187693775T patent/PT3684924T/en unknown
- 2018-09-19 DK DK18769378.3T patent/DK3684925T3/en active
- 2018-09-19 SG SG11202002367WA patent/SG11202002367WA/en unknown
- 2018-09-19 CN CN201880061036.7A patent/CN111278972B/en active Active
- 2018-09-19 AU AU2018337673A patent/AU2018337673A1/en active Pending
- 2018-09-19 KR KR1020207010863A patent/KR20200054278A/en not_active Application Discontinuation
-
2020
- 2020-03-12 IL IL273267A patent/IL273267A/en unknown
- 2020-03-17 IL IL273362A patent/IL273362A/en unknown
-
2023
- 2023-04-12 JP JP2023064820A patent/JP2023089132A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273362A (en) | Non-integrating dna vectors for the genetic modification of cells | |
| EP3645021A4 (en) | Adeno-associated viral vectors for gene therapy | |
| HK1250757A1 (en) | Nucleic acid sequence analysis from single cells | |
| GB201704402D0 (en) | Single cell DNA sequencing | |
| EP3302575A4 (en) | Genome editing vectors | |
| IL274351A (en) | Primary cell gene editing | |
| HK1257078A1 (en) | Optimized factor viii genes | |
| EP3222728A4 (en) | Method for regulating gene expression using cas9 protein expressed from two vectors | |
| SG11201706636PA (en) | Single-cell nucleic acids for high-throughput studies | |
| EP3377636A4 (en) | Cmv vectors comprising microrna recognition elements | |
| EP3568483A4 (en) | Polynucleotides and vectors for the expression of transgenes | |
| PL3433566T3 (en) | Propellant charge or grain | |
| ZA201902370B (en) | Novel paratransgenic system for the biocontrol of disease-transmitting mosquitos | |
| EP3535400A4 (en) | Plasmid vectors for expression of large nucleic acid transgenes | |
| GB201705484D0 (en) | Genetic construct | |
| LT3277807T (en) | Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters | |
| GB201708385D0 (en) | Genetic construct | |
| EP3500298A4 (en) | Regulation of tumor-associated t cells | |
| EP3794129A4 (en) | Vectors for dna vaccination | |
| EP3518941A4 (en) | Viral vectors for nuclear reprogramming | |
| GB201819021D0 (en) | Genetic construct | |
| PL3621596T3 (en) | Tablets comprising nucleic acid vectors | |
| AU2017900050A0 (en) | Polynucleotides and vectors for the expression of transgenes | |
| GB201614742D0 (en) | Containing genetic material | |
| GB201605367D0 (en) | TALEN-based genetic manipulation |